Bcl-2 is a prognostic marker and its silencing inhibits recurrence in ameloblastomas.
Jue Young KimJinsun KimShadavlonjid BazarsadIn-Ho ChaSung-Won ChoJin KimPublished in: Oral diseases (2019)
These results suggest that Bcl-2 expression is a useful biomarker to predict recurrence of ameloblastomas, and as a therapeutic target molecule to prevent recurrence of ameloblastoma.